Submission of intimation of Closure of Trading Window
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd has informed BSE that the trading window for dealing in its securities will be closed for designated persons, their relatives, and other insiders starting October 1, 2025. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter ended September 30, 2025. This is a standard compliance step under SEBI's Insider Trading Regulations to prevent insider trading ahead of the quarterly results announcement. The exact board meeting date for considering the results will be communicated later.
This is a routine regulatory filing and not an indication of any negative news. It simply restricts insiders from trading in the stock before the Q2 FY26 results are announced, which is standard practice ahead of any earnings disclosure.